GHK-Cu Australia

GHK-Cu Australia. GHK-Cu is a copper-binding tripeptide complex studied in laboratory research — glycyl-L-histidyl-L-lysine bound to a copper(II) ion — the most-researched copper-peptide in the dermal and matrix-research literature. The Elite AU Peptides GHK-Cu is independently HPLC-tested by Janoshik; the certificate of analysis is published on this page and in the lab-reports library, with the measured number and an independently verifiable Janoshik key.

Supplied in 50 mg and 100 mg lyophilised vials, AU-domestic, AUD pricing. Every batch is held until the independent HPLC report comes back within our acceptance threshold; nothing is listed without a certificate on file. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.

GHK-Cu (CAS 89030-95-5; molecular formula C14H23CuN6O4, average molecular weight ≈ 403 g/mol; composition Gly-His-Lys · Cu(II)) is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The free GHK tripeptide was first identified in human plasma by Pickart and Thaler (Nature: New Biology, 1973) — the foundational characterisation of the molecule.

Its copper-coordination chemistry and role in matrix-remodelling research were characterised by Pickart (Journal of Biomaterials Science, Polymer Edition, 2008), which describes the peptide’s high copper(II) affinity — comparable to the albumin copper-transport site — as the basis for its copper-binding and tissue-remodelling research activity.

A modern review by Pickart and Margolina (International Journal of Molecular Sciences, 2018) synthesises transcriptomic data showing GHK modulates the expression of a large number of human genes across repair and protective pathways — the gene-regulation strand of GHK-Cu research. Across more than fifty years of literature it remains the most-researched copper-peptide research compound.

GHK-Cu is also a key component of the multi-peptide GLOW70 and KLOW80 research blends (alongside BPC-157 and TB-500); see the GLOW70 product page for the co-lyophilised research-stack variant. Its copper coordination is what gives a reconstituted solution its characteristic blue colour.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, cosmetic, therapeutic, or human-use claim about this product. GHK-Cu is not TGA-approved, is not a therapeutic good, is not a cosmetic ingredient for end-use formulation, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for copper-binding and gene-expression data and protocol-specific reference values.

Reconstitute the lyophilised GHK-Cu vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. The required volume depends on the protocol’s downstream assay requirements — a 50 mg vial reconstituted in 10 mL of bacteriostatic water yields a 5 mg/mL working stock. GHK-Cu solutions are characteristically blue from the copper coordination — note the colour in your protocol notes for batch consistency.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.